MedTrace Logo

Asthma Breath Biomarker Assessment

NCT03084016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2022-10-20

No results posted yet for this study

Summary

This study aims to assess the feasibility of capturing data on exhaled breath compounds during an acute asthma exacerbation. In addition to assessing the feasibility of such a study the investigators will collect data on exploratory outcomes including the ability of breath biomarkers to distinguish between controlled and exacerbated states and their ability to differentiate between triggers of exacerbation.

Conditions

  • Asthma Acute

Sponsors & Collaborators

  • University of East Anglia

    lead OTHER

Principal Investigators

  • Andrew Wilson · University of East Anglia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03084016 on ClinicalTrials.gov